![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Final OS from NETTER-1: lutetium-177-DOTATATE in patients with midgut NETs (VJOncology) View |
![]() |
Recently Approved Drugs: Lutetium Lu 177 dotatate for treatment of GEP-NETs (ASCO Podcasts) View |
![]() |
Lu 177 DOTATATE THERAPY (Sanjeev Bagga MD) View |
![]() |
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors (The Healthcare Channel) View |
![]() |
Radioisotopic Targeting of NETS: Lutetium-177 Dotatate by Dr. Aman Chauhan (Neuroendocrine Cancer Awareness Network (NCAN) ) View |
![]() |
Living Family Life to the Fullest (American Association for Cancer Research) View |
![]() |
Neuroendocrine Tumors - Not so Rare (Grand Rounds in Urology) View |
![]() |
Lutetium-177: PSMA Guided Treatment | #ProstateCancer | #MarkScholzMD | #PCRI (Prostate Cancer Research Institute) View |
![]() |
June 2024: Dr. Aman Chauhan discusses Phase 2 LUTATHERA (Lu-177) + Triapine Study (Neuroendocrine Cancer Foundation) View |
![]() |
Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results (ecancer) View |